57 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 2 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
ALG1ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferaseDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Nucleoli fibrillar center
Endoplasmic reticulum
Colorectal cancer: 5.79e-4
Testis cancer: 6.93e-4
Expressed in all
ARHGEF4Rho guanine nucleotide exchange factor 4Plasma proteins
Predicted intracellular proteins
Testis cancer: 7.00e-4
Tissue enhanced
BST2Bone marrow stromal cell antigen 2CD markers
Plasma proteins
Predicted membrane proteins
Golgi apparatus
Plasma membrane
Cytosol
Renal cancer: 3.56e-9
Testis cancer: 4.22e-4
Breast cancer: 6.69e-4
Expressed in all
C15orf39Chromosome 15 open reading frame 39Predicted intracellular proteins
CytosolRenal cancer: 3.05e-4
Testis cancer: 6.02e-4
Melanoma: 7.94e-4
Tissue enhanced
C5AR1Complement C5a receptor 1CD markers
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Renal cancer: 1.16e-4
Cervical cancer: 4.71e-4
Testis cancer: 7.99e-4
Ovarian cancer: 9.55e-4
Tissue enhanced
CA9Carbonic anhydrase 9Enzymes
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Renal cancer: 2.22e-7
Liver cancer: 1.71e-5
Testis cancer: 9.50e-4
Tissue enhanced
CCDC74ACoiled-coil domain containing 74APredicted intracellular proteins
VesiclesRenal cancer: 1.70e-7
Glioma: 1.82e-4
Testis cancer: 4.92e-4
Breast cancer: 5.11e-4
Tissue enhanced
CCR7C-C motif chemokine receptor 7Cancer-related genes
CD markers
G-protein coupled receptors
Predicted membrane proteins
MitochondriaHead and neck cancer: 7.61e-7
Cervical cancer: 8.03e-6
Breast cancer: 3.84e-4
Testis cancer: 7.72e-4
Group enriched
CD300CCD300c moleculeCD markers
Predicted membrane proteins
Testis cancer: 8.53e-5
Tissue enhanced
CITED1Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1Predicted intracellular proteins
Nucleoplasm
Cytosol
Thyroid cancer: 3.95e-4
Testis cancer: 6.10e-4
Tissue enriched
CLCN7Chloride voltage-gated channel 7Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
NucleoplasmTestis cancer: 3.21e-4
Head and neck cancer: 5.23e-4
Expressed in all
CLEC10AC-type lectin domain family 10 member ACD markers
Predicted intracellular proteins
Predicted membrane proteins
Head and neck cancer: 1.26e-5
Testis cancer: 4.22e-4
Lung cancer: 9.24e-4
Mixed
CSF1RColony stimulating factor 1 receptorCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Vesicles
Plasma membrane
Renal cancer: 1.08e-4
Testis cancer: 4.92e-4
Mixed
CSF2RAColony stimulating factor 2 receptor alpha subunitCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Cervical cancer: 2.38e-5
Head and neck cancer: 2.81e-4
Testis cancer: 5.53e-4
Tissue enhanced
CSF3RColony stimulating factor 3 receptorCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Testis cancer: 3.79e-4
Renal cancer: 5.72e-4
Tissue enhanced
DPEP2Dipeptidase 2Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Testis cancer: 8.47e-4
Tissue enhanced
DVL1Dishevelled segment polarity protein 1Disease related genes
Plasma proteins
Predicted intracellular proteins
Testis cancer: 3.33e-4
Expressed in all
FAM105AFamily with sequence similarity 105 member AEnzymes
Predicted membrane proteins
Nucleoli
Cytosol
Pancreatic cancer: 1.02e-4
Testis cancer: 7.62e-4
Mixed
FCHSD1FCH and double SH3 domains 1Predicted intracellular proteins
Nucleoplasm
Cytosol
Renal cancer: 6.19e-6
Urothelial cancer: 1.21e-4
Testis cancer: 4.77e-4
Breast cancer: 8.62e-4
Mixed
FKBP15FK506 binding protein 15Predicted intracellular proteins
Nucleoli
Cytosol
Testis cancer: 4.92e-4
Expressed in all
FPR3Formyl peptide receptor 3G-protein coupled receptors
Predicted membrane proteins
Testis cancer: 9.13e-4
Mixed
FUNDC1FUN14 domain containing 1Predicted intracellular proteins
Urothelial cancer: 2.58e-4
Testis cancer: 8.35e-4
Expressed in all
GGA2Golgi associated, gamma adaptin ear containing, ARF binding protein 2Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatusCervical cancer: 1.71e-5
Renal cancer: 3.91e-5
Head and neck cancer: 9.70e-5
Lung cancer: 1.68e-4
Testis cancer: 4.15e-4
Expressed in all
GGT5Gamma-glutamyltransferase 5Enzymes
Predicted intracellular proteins
Predicted secreted proteins
Nucleoli fibrillar centerRenal cancer: 6.36e-5
Stomach cancer: 4.06e-4
Testis cancer: 6.97e-4
Mixed
GIMAP1GTPase, IMAP family member 1Predicted membrane proteins
Endoplasmic reticulumLiver cancer: 1.09e-4
Testis cancer: 6.12e-4
Tissue enhanced
GIMAP8GTPase, IMAP family member 8Predicted intracellular proteins
Testis cancer: 8.47e-4
Mixed
GUCY1A3Guanylate cyclase 1 soluble subunit alphaDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
NucleusLung cancer: 2.38e-4
Testis cancer: 3.59e-4
Renal cancer: 7.59e-4
Tissue enhanced
GUCY1B3Guanylate cyclase 1 soluble subunit betaEnzymes
Plasma proteins
Predicted intracellular proteins
CytosolRenal cancer: 2.42e-4
Testis cancer: 3.23e-4
Expressed in all
HELZ2Helicase with zinc finger 2Plasma proteins
Predicted intracellular proteins
Testis cancer: 4.92e-4
Mixed
HRASLSHRAS like suppressorPredicted membrane proteins
Focal adhesion sites
Cytosol
Testis cancer: 4.36e-4
Group enriched
IFT52Intraflagellar transport 52Disease related genes
Predicted intracellular proteins
CytosolLiver cancer: 3.30e-6
Testis cancer: 3.33e-4
Expressed in all
IL1RNInterleukin 1 receptor antagonistCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 2.66e-6
Endometrial cancer: 3.00e-4
Pancreatic cancer: 6.85e-4
Testis cancer: 8.23e-4
Tissue enhanced
IQCCIQ motif containing CPredicted intracellular proteins
VesiclesPancreatic cancer: 8.23e-5
Testis cancer: 3.79e-4
Lung cancer: 5.65e-4
Tissue enhanced
ITGAMIntegrin subunit alpha MCancer-related genes
CD markers
Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Renal cancer: 6.93e-5
Liver cancer: 3.43e-4
Testis cancer: 6.93e-4
Tissue enhanced
LAT2Linker for activation of T-cells family member 2Disease related genes
Predicted secreted proteins
Renal cancer: 4.10e-4
Testis cancer: 6.10e-4
Tissue enhanced
LITAFLipopolysaccharide induced TNF factorDisease related genes
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Vesicles
Cytosol
Glioma: 1.78e-4
Testis cancer: 6.25e-4
Expressed in all
LRRC25Leucine rich repeat containing 25Predicted membrane proteins
Testis cancer: 6.93e-4
Tissue enhanced
LST1Leukocyte specific transcript 1Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 5.97e-5
Testis cancer: 7.62e-4
Cervical cancer: 7.89e-4
Tissue enhanced
LY86Lymphocyte antigen 86Predicted secreted proteins
Testis cancer: 5.61e-4
Tissue enhanced
NEK6NIMA related kinase 6Enzymes
Predicted intracellular proteins
Transporters
Nucleoplasm
Microtubule organizing center
Cytosol
Testis cancer: 7.66e-4
Expressed in all
PAG1Phosphoprotein membrane anchor with glycosphingolipid microdomains 1Predicted intracellular proteins
Vesicles
Plasma membrane
Renal cancer: 1.24e-6
Testis cancer: 6.82e-4
Mixed
PIN4Peptidylprolyl cis/trans isomerase, NIMA-interacting 4Enzymes
Plasma proteins
Predicted intracellular proteins
Nucleus
Nucleoli
Testis cancer: 2.58e-4
Urothelial cancer: 2.66e-4
Lung cancer: 6.37e-4
Expressed in all
PPP6R3Protein phosphatase 6 regulatory subunit 3Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Cytosol
Testis cancer: 8.23e-4
Expressed in all
PRKRAProtein activator of interferon induced protein kinase EIF2AK2Disease related genes
Predicted intracellular proteins
Nucleoplasm
Cytosol
Liver cancer: 8.33e-5
Testis cancer: 5.45e-4
Expressed in all
PRR36Proline rich 36Predicted intracellular proteins
Nucleus
Golgi apparatus
Testis cancer: 7.74e-4
Tissue enriched
PTGIRProstaglandin I2 (prostacyclin) receptor (IP)FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 2.09e-8
Testis cancer: 1.74e-4
Tissue enhanced
RAB37RAB37, member RAS oncogene familyPlasma proteins
Predicted intracellular proteins
Renal cancer: 8.80e-6
Testis cancer: 9.27e-4
Mixed
SGSHN-sulfoglucosamine sulfohydrolaseDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 2.66e-4
Lung cancer: 2.72e-4
Pancreatic cancer: 3.10e-4
Testis cancer: 5.37e-4
Liver cancer: 7.71e-4
Expressed in all
SIGLEC1Sialic acid binding Ig like lectin 1CD markers
Predicted intracellular proteins
Predicted membrane proteins
Renal cancer: 8.69e-5
Testis cancer: 4.36e-4
Mixed
SNX31Sorting nexin 31Predicted intracellular proteins
Transporters
Nucleoplasm
Golgi apparatus
Cytosol
Testis cancer: 1.47e-4
Tissue enhanced
Page of 2 | next »